Eudamed will not improve safety without real harmonisation
This article was originally published in Clinica
Executive Summary
The European Commission has finally made use of the European Union’s medical devices database (Eudamed) obligatory from May 2011 (see www.clinica.co.uk, 19 April 2010: European Regulatory Database to become mandatory next year). The database itself has been a long time in the making, having been first conceived of in 1998, but it is finally here and one of its major aims is to make the use of medical devices safer. This means that it will facilitate the use of the Medical Device Vigilance System (MDVS), by helping member states to communicate about adverse incidents involving devices.
You may also be interested in...
MHRA’s Beneficial EU Relationship And Profitable Synergies With NICE: An Interview With Michael Rawlins
In December, Michael Rawlins was appointed head of the U.K.’s Medicines and Healthcare products Regulatory Agency. He recognizes the MHRA’s mutually beneficial relationship with European counterparts and is looking to safeguard synergies with other national regulatory bodies and NICE.
EMA Acts To Freeze GVK Drugs, Guard Against Shortages
The EMA has recommended suspension of some 700 drug formations linked with Indian clinical trials company GVK Biosciences, but assures national agencies that this won’t result in shortages or safety issues.
EMA Acts To Freeze Drugs Linked to GVK Bio, Guards Against Shortages
EMA has recommended suspension of some 700 drug formations linked with Indian clinical trials company GVK Biosciences, but assures national agencies that this won’t result in shortages or safety issues.